| Style | Citing Format |
|---|---|
| MLA | Maccari ME, et al.. "Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase Δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Δ Syndrome Registry." Frontiers in Immunology, vol. 9, no. MAR, 2018, pp. -. |
| APA | Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, Baris S, Barzaghi F, Baxendale H, Buckland M, Burns SO, Cancrini C, Cant A, Cathebras P, Cavazzana M, Chandra A, Conti F, Coulter T, Devlin LA, ... Ehl S (2018). Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase Δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Δ Syndrome Registry. Frontiers in Immunology, 9(MAR), -. |
| Chicago | Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, Baris S, et al.. "Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase Δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Δ Syndrome Registry." Frontiers in Immunology 9, no. MAR (2018): -. |
| Harvard | Maccari ME et al. (2018) 'Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase Δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Δ Syndrome Registry', Frontiers in Immunology, 9(MAR), pp. -. |
| Vancouver | Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, et al.. Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase Δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Δ Syndrome Registry. Frontiers in Immunology. 2018;9(MAR):-. |
| BibTex | @article{ author = {Maccari ME and Abolhassani H and Aghamohammadi A and Aiuti A and Aleinikova O and Bangs C and Baris S and Barzaghi F and Baxendale H and Buckland M and Burns SO and Cancrini C and Cant A and Cathebras P and Cavazzana M and Chandra A and Conti F and Coulter T and Devlin LA and Edgar JDM and Faust S and Fischer A and Prat MG and Hammarstrom L and Heeg M and Jolles S and Karakocaydiner E and Kindle G and Kiykim A and Kumararatne D and Grimbacher B and Longhurst H and Mahlaoui N and Milota T and Moreira F and Moshous D and Mukhina A and Neth O and Neven B and Nieters A and Olbrich P and Ozen A and Schmid JP and Picard C and Prader S and Rae W and Reichenbach J and Rusch S and Savic S and Scarselli A and Scheible R and Sediva A and Sharapova SO and Shcherbina A and Slatter M and Solerpalacin P and Stanislas A and Suarez F and Tucci F and Uhlmann A and Montfrans J and Warnatz K and Williams AP and Wood P and Kracker S and Condliffe AM and Ehl S}, title = {Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase Δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Δ Syndrome Registry}, journal = {Frontiers in Immunology}, volume = {9}, number = {MAR}, pages = {-}, year = {2018} } |
| RIS | TY - JOUR AU - Maccari ME AU - Abolhassani H AU - Aghamohammadi A AU - Aiuti A AU - Aleinikova O AU - Bangs C AU - Baris S AU - Barzaghi F AU - Baxendale H AU - Buckland M AU - Burns SO AU - Cancrini C AU - Cant A AU - Cathebras P AU - Cavazzana M AU - Chandra A AU - Conti F AU - Coulter T AU - Devlin LA AU - Edgar JDM AU - Faust S AU - Fischer A AU - Prat MG AU - Hammarstrom L AU - Heeg M AU - Jolles S AU - Karakocaydiner E AU - Kindle G AU - Kiykim A AU - Kumararatne D AU - Grimbacher B AU - Longhurst H AU - Mahlaoui N AU - Milota T AU - Moreira F AU - Moshous D AU - Mukhina A AU - Neth O AU - Neven B AU - Nieters A AU - Olbrich P AU - Ozen A AU - Schmid JP AU - Picard C AU - Prader S AU - Rae W AU - Reichenbach J AU - Rusch S AU - Savic S AU - Scarselli A AU - Scheible R AU - Sediva A AU - Sharapova SO AU - Shcherbina A AU - Slatter M AU - Solerpalacin P AU - Stanislas A AU - Suarez F AU - Tucci F AU - Uhlmann A AU - Montfrans J AU - Warnatz K AU - Williams AP AU - Wood P AU - Kracker S AU - Condliffe AM AU - Ehl S TI - Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase Δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase Δ Syndrome Registry JO - Frontiers in Immunology VL - 9 IS - MAR SP - EP - PY - 2018 ER - |